日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Surgical Outcomes Following Neoadjuvant-Targeted Therapy for Advanced Differentiated Thyroid Cancer-Real-World Data

新辅助靶向治疗后晚期分化型甲状腺癌的手术结果——真实世界数据

期刊:Clinical Endocrinology
影响因子:2.4
doi:10.1111/cen.70054
Dorman, Alexandra; Shendler, Genady; Warshavsky, Anton; Muhanna, Nidal; Horowitz, Gilad; Furman, Liyona Kampel; Shilo, Shahaf; Joshua, Ben-Zion; Alon, Eran; Remer, Eric; Avior, Galit; Khafif, Avi; Gutfeld, Orit; Izkhakov, Elena; Mansour, Jobran; Finkel, Inbar
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi-Center Retrospective Cohort

靶向治疗时代分化型甲状腺癌脑转移：一项多中心回顾性队列研究

期刊:Head and Neck-Journal for the Sciences and Specialties of the Head and Neck
影响因子:2.2
doi:10.1002/hed.70139
Kampel, Liyona; Edalati, Shaun; Yosefof, Eyal; Warshavsky, Anton; Horowitz, Gilad; Muhanna, Nidal; Shoffel-Havakuk, Hagit; Robenshtok, Eyal; Popovtzer, Aron; Finkel, Inbar
肿瘤
肿瘤免疫
神经科学
甲状腺癌
免疫/内分泌
发表日期：2026
文献求助 收藏

Different Immunohistochemical Expression of CTLA-4 in Diffuse Large B-Cell Lymphoma and Its Associated Prognostic Factors

弥漫性大B细胞淋巴瘤中CTLA-4的不同免疫组织化学表达及其相关预后因素

期刊:Asian Pacific Journal of Cancer Prevention
影响因子:
doi:10.31557/APJCP.2025.26.2.405
Rifani, Liyona; Ham, Maria Francisca; Khoirunnisa, Dina; Harahap, Agnes Stephanie
B细胞
IHC
淋巴瘤
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Mutated TP53 in Circulating Tumor DNA as a Risk Level Biomarker in Head and Neck Squamous Cell Carcinoma Patients

循环肿瘤DNA中TP53突变作为头颈部鳞状细胞癌患者的风险水平生物标志物

期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom13091418
Kampel, Liyona; Feldstein, Sara; Tsuriel, Shlomo; Hannes, Victoria; Carmel Neiderman, Narin N; Horowitz, Gilad; Warshavsky, Anton; Leider-Trejo, Leonor; Hershkovitz, Dov; Muhanna, Nidal
细胞生物学
肿瘤
P53
肿瘤免疫
发表日期：2023
文献求助 收藏

The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis

40基因表达谱（40-GEP）检测在皮肤鳞状细胞癌中的预后价值和临床应用：系统评价和荟萃分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15092456
Masarwy, Razan; Shilo, Shahaf; Carmel Neiderman, Narin Nard; Kampel, Liyona; Horowitz, Gilad; Muhanna, Nidal; Mansour, Jobran
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

CD24 in Head and Neck Malignancies-An Uprising Biomarker?

CD24在头颈部恶性肿瘤中的作用——一种新兴的生物标志物？

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm13121631
Carmel Neiderman, Narin N; Shapira, Shiran; Klein, Linor; Rafael, Dor; Gorelik, Gregory; Kampel, Liyona; Arber, Nadir; Muhanna, Nidal
肿瘤
肿瘤免疫
CD24
头颈癌
CD2
发表日期：2023
文献求助 收藏

Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer: A Systematic Review and Meta-analysis

可切除头颈癌新辅助PD-1/PD-L1抑制剂治疗：系统评价和荟萃分析

期刊:Jama Otolaryngology-Head & Neck Surgery
影响因子:5.6
doi:10.1001/jamaoto.2021.2191
Masarwy, Razan; Kampel, Liyona; Horowitz, Gilad; Gutfeld, Orit; Muhanna, Nidal
肿瘤
肿瘤免疫
PD-L1
头颈癌
PD-1
发表日期：2021
文献求助 收藏